Podcast-Thyroid
Learning Objectives
At the end of this course, participants should be able to:
- Recognize the Spectrum of Thyroid Disorders in Pediatrics
- Interpret Thyroid Function Tests and Their Clinical Relevance
- Distinguish Between Pathological and Transient Thyroid Abnormalities
- Understand Referral Guidelines for Pediatric Endocrinology
- Apply Clinical Judgment in Managing Thyroid Disorders
Intended Audience:
This online course is designed for pediatricians, family physicians, and pediatric endocrinologists.
Abstract:
In this episode, Dr. Eyal Ben-Isaac and Dr. Anna Ryabets discuss thyroid disorders in pediatric patients, ranging from congenital hypothyroidism in neonates to acquired thyroid dysfunction in older children. They explore the broad spectrum of clinical presentations, including overt and subclinical hypo- and hyperthyroidism, and discuss special populations such as children with Trisomy 21 and obesity who are at increased risk for thyroid abnormalities. The conversation focuses on the diagnostic approach, including when to order thyroid function tests, how to interpret results, and the role of thyroid antibody testing. Dr. Ryabets emphasizes the importance of clinical judgment in deciding when to refer patients to a pediatric endocrinologist for further evaluation and management. While treatment is not discussed in detail, the episode underscores the need for early recognition and appropriate referral to ensure optimal outcomes.
Assessment and Earning CME Credit:
This course in English is not CME-accredited. However, it provides valuable educational content that can enhance your knowledge and skills in the subject matter. To receive CME credit for this course in Armenia, you must take the course in Armenian and complete the post-course quiz. You have three chances to achieve a passing score of 70%. Once you pass the quiz, we will send your information to the Armenian Ministry of Health for credits.
Anna Ryabets-Lienhard, DO
Anna Ryabets-Lienhard, D.O. is the Medical Director of Metabolic Bone and Mineral Disorders Program at the Division of Endocrinology, Diabetes, and Metabolism, Children’s Hospital Los Angeles (CHLA), and an Assistant Professor of Clinical Pediatrics, Keck School of Medicine of the University of Southern California. She is a board-certified pediatric endocrinologist and an attending physician at CHLA. Dr. Ryabets-Lienhard completed her pediatric residency and pediatric endocrinology fellowship at CHLA. Her research and clinical focus are on primary and secondary pediatric osteoporosis, such as Osteogenesis Imperfecta and Glucocorticoid-Induced Osteoporosis, as well as rickets and mineral disorders. She is a site principal investigator on multiple clinical trials and a co-principal investigator on a multidisciplinary multisite study of metabolic and orthopedic outcomes of patients with congenital forms of rickets. Dr. Ryabets-Lienhardis on the Board of Directors for the Human Growth Foundation and co-chair of the Drugs and Therapeutics Committee of the Pediatric Endocrine Society, USA.
